IMR Press / RCM / Volume 9 / Issue 1 / pii/1560999973218-1763620520

Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on as a courtesy and upon agreement with MedReviews, LLC.

Open Access Review
Early Detection and Integrated Management of Dysglycemia in Cardiovascular Disease: A Key Factor for Decreasing the Likelihood of Future Events
Show Less
1 Cardiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
Rev. Cardiovasc. Med. 2008, 9(1), 29–38;
Published: 30 March 2008
Dysglycemia is widespread among patients with coronary artery disease. It is indeed more common than normoglycemia in these patients. Coexistence of cardiovascular disease and dysglycemia presents significant health risks, and evidence suggests that both conditions should be treated early to reduce the development of complications. Guidelines recommend testing for prediabetes and type 2 diabetes in the cardiology setting and highlight the use of therapies that treat metabolic and cardiovascular risk factors. Blood glucose levels have previously been the interest of diabetologists, but modern integrated management approaches should include assessment by a cardiologist. We propose that postprandial blood glucose testing be carried out routinely in all patients with coronary artery disease, and that newly diagnosed dysglycemia be actively managed.
Oral glucose tolerance test
Glucose-lowering drugs
Cardiovascular disease risk
Back to top